40/66
3.0 / 5 stars
All 66 Win/Lose results and 54 gray no-data contests shown below
SMTI Roast Me summary
Sanara MedTech Inc. (SMTI). Every strict quarterly win earns 1 point. A loss or tie earns 0. A contest with no data is a gray cell, neither a win nor a loss, and leaves the total: stars are 5 × points won ÷ contests with data.
- 2026-Q2: Total return Win; Revenue growth No data; EPS growth No data.
- 2026-Q1: Total return Lose; Revenue growth No data; EPS growth No data.
- 2025-Q4: Total return Lose; Revenue growth Win; EPS growth No data.
- 2025-Q3: Total return Win; Revenue growth No data; EPS growth No data.
Trailing 1 year (4 quarters): 3 wins, 2 losses, 7 no dataLast fetched: 24 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/1 |
WinSMTI / S&P 37.31% / 15.20% |
No dataSMTI / S&P / 15.00% |
No dataSMTI / S&P / 50.40% |
| 2026-Q10/1 |
LoseSMTI / S&P -26.42% / -4.33% |
No dataSMTI / S&P / 11.30% |
No dataSMTI / S&P / 27.70% |
| 2025-Q41/2 |
LoseSMTI / S&P -26.41% / 2.65% |
WinSMTI / S&P 18.97% / 9.00% |
No dataSMTI / S&P / 13.40% |
| 2025-Q31/1 |
WinSMTI / S&P 11.76% / 8.12% |
No dataSMTI / S&P / 4.61% |
No dataSMTI / S&P / 13.45% |
| 2025-Q20/1 |
LoseSMTI / S&P -8.03% / 10.94% |
No dataSMTI / S&P / 4.83% |
No dataSMTI / S&P / 10.63% |
| 2025-Q10/1 |
LoseSMTI / S&P -7.02% / -4.27% |
No dataSMTI / S&P / 4.98% |
No dataSMTI / S&P / 10.57% |
| 2024-Q42/2 |
WinSMTI / S&P 9.79% / 2.41% |
WinSMTI / S&P 33.36% / 5.25% |
No dataSMTI / S&P / 6.15% |
| 2024-Q31/1 |
WinSMTI / S&P 7.16% / 5.89% |
No dataSMTI / S&P / 5.89% |
No dataSMTI / S&P / 6.11% |
| 2024-Q20/1 |
LoseSMTI / S&P -23.73% / 4.28% |
No dataSMTI / S&P / 5.38% |
No dataSMTI / S&P / 5.12% |
| 2024-Q10/1 |
LoseSMTI / S&P -9.98% / 10.56% |
No dataSMTI / S&P / 5.71% |
No dataSMTI / S&P / 5.59% |
| 2023-Q42/2 |
WinSMTI / S&P 32.03% / 11.69% |
WinSMTI / S&P 41.77% / 6.81% |
No dataSMTI / S&P / 7.78% |
| 2023-Q30/1 |
LoseSMTI / S&P -22.37% / -3.27% |
No dataSMTI / S&P / 7.52% |
No dataSMTI / S&P / -5.03% |
| 2023-Q20/1 |
LoseSMTI / S&P -2.79% / 8.74% |
No dataSMTI / S&P / 9.50% |
No dataSMTI / S&P / -8.57% |
| 2023-Q10/1 |
LoseSMTI / S&P -9.34% / 7.50% |
No dataSMTI / S&P / 10.77% |
No dataSMTI / S&P / -15.69% |
| 2022-Q42/2 |
WinSMTI / S&P 53.25% / 7.56% |
WinSMTI / S&P 89.87% / 11.88% |
No dataSMTI / S&P / -17.99% |
| 2022-Q31/1 |
WinSMTI / S&P 42.33% / -4.88% |
No dataSMTI / S&P / 13.47% |
No dataSMTI / S&P / -1.41% |
| 2022-Q20/1 |
LoseSMTI / S&P -26.76% / -16.10% |
No dataSMTI / S&P / 13.71% |
No dataSMTI / S&P / 11.04% |
| 2022-Q11/1 |
WinSMTI / S&P -3.62% / -4.60% |
No dataSMTI / S&P / 15.97% |
No dataSMTI / S&P / 42.23% |
| 2021-Q41/2 |
LoseSMTI / S&P -13.82% / 11.03% |
WinSMTI / S&P 54.90% / 15.00% |
No dataSMTI / S&P / 96.40% |
| 2021-Q31/2 |
LoseSMTI / S&P -7.20% / 0.58% |
WinSMTI / S&P 64.60% / 10.77% |
No dataSMTI / S&P / 69.42% |
| 2021-Q22/2 |
WinSMTI / S&P 18.62% / 8.55% |
WinSMTI / S&P 69.58% / 6.58% |
No dataSMTI / S&P / 51.81% |
| 2021-Q11/2 |
LoseSMTI / S&P -37.58% / 6.17% |
WinSMTI / S&P 48.05% / -1.06% |
No dataSMTI / S&P / 7.39% |
| 2020-Q42/2 |
WinSMTI / S&P 78.21% / 12.15% |
WinSMTI / S&P 32.47% / -3.72% |
No dataSMTI / S&P / -33.42% |
| 2020-Q32/2 |
WinSMTI / S&P 55.56% / 8.93% |
WinSMTI / S&P 102.31% / -2.04% |
No dataSMTI / S&P / -27.10% |
| 2020-Q22/2 |
WinSMTI / S&P 78.39% / 20.54% |
WinSMTI / S&P 120.85% / -0.46% |
No dataSMTI / S&P / -27.11% |
| 2020-Q11/2 |
LoseSMTI / S&P -37.33% / -19.60% |
WinSMTI / S&P 147.86% / 3.47% |
No dataSMTI / S&P / -14.75% |
| 2019-Q42/2 |
WinSMTI / S&P 89.41% / 9.07% |
WinSMTI / S&P 101.56% / 5.36% |
No dataSMTI / S&P / 2.99% |
| 2019-Q32/2 |
WinSMTI / S&P 54.26% / 1.70% |
WinSMTI / S&P 13.00% / 5.02% |
No dataSMTI / S&P / 0.21% |
| 2019-Q20/2 |
LoseSMTI / S&P -8.17% / 4.30% |
LoseSMTI / S&P -4.71% / 6.64% |
No dataSMTI / S&P / 8.65% |
| 2019-Q11/2 |
WinSMTI / S&P 100.00% / 13.65% |
LoseSMTI / S&P -4.48% / 8.12% |
No dataSMTI / S&P / 14.29% |
| 2018-Q40/2 |
LoseSMTI / S&P -57.14% / -13.52% |
LoseSMTI / S&P -7.41% / 9.05% |
No dataSMTI / S&P / 18.23% |
| 2018-Q31/2 |
LoseSMTI / S&P 0.00% / 7.71% |
WinSMTI / S&P 17.88% / 10.21% |
No dataSMTI / S&P / 19.06% |
| 2018-Q22/2 |
WinSMTI / S&P 40.00% / 3.43% |
WinSMTI / S&P 20.24% / 9.03% |
No dataSMTI / S&P / 14.46% |
| 2018-Q11/2 |
LoseSMTI / S&P -16.67% / -0.76% |
WinSMTI / S&P 10.69% / 7.68% |
No dataSMTI / S&P / 12.46% |
| 2017-Q41/2 |
LoseSMTI / S&P -14.29% / 6.64% |
WinSMTI / S&P 14.47% / 7.03% |
No dataSMTI / S&P / 13.82% |
| 2017-Q31/2 |
LoseSMTI / S&P -12.50% / 4.48% |
WinSMTI / S&P 42.11% / 5.68% |
No dataSMTI / S&P / 17.57% |
| 2017-Q21/2 |
LoseSMTI / S&P -11.11% / 3.09% |
WinSMTI / S&P 56.64% / 4.83% |
No dataSMTI / S&P / 17.74% |
| 2017-Q12/2 |
WinSMTI / S&P 125.00% / 6.07% |
WinSMTI / S&P 74.26% / 3.67% |
No dataSMTI / S&P / 13.32% |
| 2016-Q41/2 |
LoseSMTI / S&P 0.00% / 3.82% |
WinSMTI / S&P 63.33% / 2.09% |
No dataSMTI / S&P / 7.05% |
| 2016-Q31/2 |
LoseSMTI / S&P -42.86% / 3.85% |
WinSMTI / S&P 31.80% / 0.20% |
No dataSMTI / S&P / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | SMTI total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 2.67% | 20.78% |
| Annualized return | 2.67% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | SMTI total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 1.65% | 83.14% |
| Annualized return | 0.33% | 12.86% |
10Y · 2016-09-01 to 2026-08-28
| Metric | SMTI total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 591.20% | 319.30% |
| Annualized return | 21.33% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-24.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| Lifeward Ltd. (LFWD) | $0.021B |